Acuitas Investments, LLC Graphite Bio, Inc. Transaction History

Acuitas Investments, LLC

  • $177 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024
SELL
$2.24 - $2.66 $2,652 - $3,149
-1,184 Reduced 0.6%
194,578 $509,000
Q3 2023

Oct 27, 2023
SELL
$2.18 - $2.77 $15 - $19
-7 Reduced -0.0%
195,762 $485,000
Q2 2023

Aug 07, 2023
BUY
$2.47 - $3.38 $483,549 - $661,699
195,769 New
195,769 $508,000

Others Institutions Holding GRPH

# of Institutions
3
Shares Held
637K
Call Options Held
0
Put Options Held
0
View Full List

About Graphite Bio, Inc.

GRPH Quotes by TradingView
  • Ticker GRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,211,200
  • Description
  • Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...
More about GRPH
Track This Portfolio

Track Acuitas Investments, LLC Portfolio

Follow Acuitas Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuitas Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuitas Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email